세계의 연속 혈당 모니터링 시장 보고서(2025년)
Continuous Glucose Monitoring Global Market Report 2025
상품코드 : 1764292
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

연속 혈당 모니터링 시장 규모는 향후 수년간 급속한 성장이 예상되고 있습니다. 예측 기간의 성장은 개인화 및 정밀의료에 중점을 둡니다. 원격 의료 및 원격 환자 모니터링을 채택합니다. 재택 포도당 모니터링에의 기호 증가, 신흥 지역에서 시장 침투의 확대에 기인한다고 생각됩니다. 예측 기간중의 주요 동향으로서는 임베디드형 디바이스의 소형화, 클로즈드 루프 인슐린 전달 시스템의 개발, 전자 차트와의 통합, 피트니스 트래커나 스마트 워치와의 호환성, 피부 접착 재료의 진보 등이 있습니다.

당뇨병의 유병률 증가는 향후 수년간 연속 혈당 모니터링 시장의 성장을 가속할 것으로 예측됩니다. 하지만 비만과 인슐린 기능 저하의 원인이 되고 있습니다. 연속 혈당 모니터링은 실시간 혈당 동향을 제공함으로써 당뇨병 관리를 지원하여 보다 좋은 포도당 컨트롤을 위한 식사, 투약, 신체 활동의 시기 적절한 조정을 가능하게 합니다. 예를 들어, 2023년 11월, 미국에 기반을 둔 비영리 단체인 미국당뇨병협회는 2022년에 미국 인구의 약 7.6%인 약 2,550만 명이 당뇨병 진단을 받았으며, 이는 전년 대비 3% 증가한 수치라고 보고했습니다.

연속 혈당 모니터링 시장의 주요 기업은 정확성, 실시간 추적, 환자 편의성을 향상시키기 위해 센서식 포도당 모니터 등의 혁신적인 제품 개발에 주력하고 있습니다. 예를 들어, 2024년 8월, 미국에 본사를 둔 의료 서비스 회사인 DexCom, Inc.는 인슐린을 사용하지 않는 성인을 위해 설계된 최초의 일반의약품(OTC) 연속 혈당 측정기(CGM)인 Stelo를 출시했습니다. 인사이트과 동향 분석을 제공하여 사용자가 식사, 운동, 수면 등의 요인이 포도당 수치에 어떻게 영향을 미치는지 이해하는 데 도움이 되며, 보다 스마트한 라이프스타일 결정을 가능하게 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

Continuous glucose monitoring (CGM) is a medical technology that continuously measures glucose levels in real time throughout the day and night using a small sensor placed under the skin. It assists people with diabetes in managing their condition by providing ongoing data and alerts for high or low blood sugar levels.

The key components of continuous glucose monitoring systems include transmitters, sensors, and receivers. Transmitters are devices that send signals, such as radio waves or electrical impulses, from one point to another for communication or control. These systems are utilized by both adults and children and cater to a range of end users, including hospitals, home care environments, diagnostic centers, clinics, and other healthcare facilities.

The continuous glucose monitoring market research report is one of a series of new reports from The Business Research Company that cover continuous glucose monitoring market statistics, including the continuous glucose monitoring industry's global market size, regional shares, competitors with the continuous glucose monitoring market share, detailed continuous glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous glucose monitoring market. This continuous glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The continuous glucose monitoring market size has grown rapidly in recent years. It will grow from $8.20 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%./b> The growth during the historic period can be attributed to the rising prevalence of diabetes, increasing awareness of diabetes management, growing demand for real-time glucose monitoring, greater adoption of minimally invasive technologies, and higher healthcare spending in developed nations.

The continuous glucose monitoring market size is expected to see rapid growth in the next few years. It will grow to $16.45 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%./b> The growth in the forecast period can be attributed to the increasing emphasis on personalized and precision medicine, the rising adoption of telehealth and remote patient monitoring, an enhanced focus on preventive healthcare and early diagnosis, greater preference for home-based glucose monitoring, and expanding market penetration in emerging regions. Key trends during the forecast period include miniaturization of implantable devices, development of closed-loop insulin delivery systems, integration with electronic health records, compatibility with fitness trackers and smartwatches, and advancements in skin-adhesive materials.

The increasing prevalence of diabetes is expected to drive the growth of the continuous glucose monitoring market in the coming years. Diabetes is a chronic condition where the body either produces insufficient insulin or cannot effectively use the insulin it produces, leading to elevated blood sugar (glucose) levels. This rise in diabetes cases is mainly due to unhealthy diets rich in sugars, fats, and processed foods, which contribute to obesity and impaired insulin function. Continuous glucose monitoring supports diabetes management by providing real-time blood sugar trends, allowing timely adjustments to diet, medication, and physical activity for better glucose control. For example, in November 2023, the American Diabetes Association, a U.S.-based non-profit organization, reported that in 2022, approximately 25.5 million people in the U.S.-about 7.6% of the population-were diagnosed with diabetes, marking a 3% increase compared to previous years. Thus, the rising prevalence of diabetes is fueling growth in the continuous glucose monitoring market.

Leading companies in the continuous glucose monitoring market are focusing on developing innovative products such as sensor-based glucose monitors to improve accuracy, real-time tracking, and patient convenience. Sensor-based glucose monitors continuously measure blood sugar levels using a small sensor inserted under the skin. For example, in August 2024, DexCom, Inc., a U.S.-based healthcare company, launched Stelo, the first over-the-counter (OTC) continuous glucose monitor (CGM) designed for adults who do not use insulin. Stelo provides real-time, 24/7 glucose readings via a small sensor worn on the back of the upper arm, sending data directly to a smartphone without the need for a prescription or fingersticks. The device offers personalized insights and trend analysis, helping users understand how factors such as diet, exercise, and sleep affect their glucose levels, enabling smarter lifestyle decisions. The sensor lasts up to 15 days, integrates with health apps, and is ideal for people with Type 2 diabetes not using insulin, those with prediabetes, or anyone monitoring their glucose health.

In September 2023, Abbott Laboratories, a U.S.-based healthcare company, acquired Bigfoot Biomedical for an undisclosed sum. Through this acquisition, Abbott seeks to strengthen its position in diabetes care by enhancing its Freestyle Libre continuous glucose monitoring technology and advancing connected solutions to make diabetes management more personalized and precise. Bigfoot Biomedical Inc., also based in the U.S., is a medical technology company that provides a diabetes management system integrating continuous glucose monitoring (CGM) technology.

Major players in the continuous glucose monitoring market are Roche Diabetes Care, Abbott Laboratories, Medtronic plc, Texas Instruments Inc., Microchip Technology Inc., Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Zillion Technologies Inc., Bionime Corporation, Biolinq Inc., Beta Bionics Inc., AgaMatrix Inc., A. Menarini Diagnostics S.r.l, Senseonics Holdings Inc., Medtrum Technologies Inc., Nemaura Medical Inc.

North America was the largest region in the continuous glucose monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in continuous glucose monitoring report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous glucose monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The continuous glucose monitoring market consists of revenues earned by entities by providing services such as real-time glucose tracking, remote patient monitoring, and data analytics for personalized diabetes management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring market also includes sales of Integrated insulin pumps, mobile and wearable apps and cloud-based data management platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Glucose Monitoring Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous glucose monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for continuous glucose monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The continuous glucose monitoring market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Continuous Glucose Monitoring Market Characteristics

3. Continuous Glucose Monitoring Market Trends And Strategies

4. Continuous Glucose Monitoring Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Continuous Glucose Monitoring Growth Analysis And Strategic Analysis Framework

6. Continuous Glucose Monitoring Market Segmentation

7. Continuous Glucose Monitoring Market Regional And Country Analysis

8. Asia-Pacific Continuous Glucose Monitoring Market

9. China Continuous Glucose Monitoring Market

10. India Continuous Glucose Monitoring Market

11. Japan Continuous Glucose Monitoring Market

12. Australia Continuous Glucose Monitoring Market

13. Indonesia Continuous Glucose Monitoring Market

14. South Korea Continuous Glucose Monitoring Market

15. Western Europe Continuous Glucose Monitoring Market

16. UK Continuous Glucose Monitoring Market

17. Germany Continuous Glucose Monitoring Market

18. France Continuous Glucose Monitoring Market

19. Italy Continuous Glucose Monitoring Market

20. Spain Continuous Glucose Monitoring Market

21. Eastern Europe Continuous Glucose Monitoring Market

22. Russia Continuous Glucose Monitoring Market

23. North America Continuous Glucose Monitoring Market

24. USA Continuous Glucose Monitoring Market

25. Canada Continuous Glucose Monitoring Market

26. South America Continuous Glucose Monitoring Market

27. Brazil Continuous Glucose Monitoring Market

28. Middle East Continuous Glucose Monitoring Market

29. Africa Continuous Glucose Monitoring Market

30. Continuous Glucose Monitoring Market Competitive Landscape And Company Profiles

31. Continuous Glucose Monitoring Market Other Major And Innovative Companies

32. Global Continuous Glucose Monitoring Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Continuous Glucose Monitoring Market

34. Recent Developments In The Continuous Glucose Monitoring Market

35. Continuous Glucose Monitoring Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기